Pharmacological Treatment of Cardiac Failure Flashcards

(37 cards)

1
Q

Left Ventricular Systolic Dysfunction (LVSD) =
Heart failure with reduced ejection fraction (HFrEF)

Aims for treatment

A
  • Relieve symptoms
  • Improve exercise tolerance
  • Reduce incidence of acute exacerbations
  • Reduce mortality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

LVSD strategies fro treatment

A
  • ↑ cardiac contrac$lity
  • ↓ preload and/or a’erload in order to ↓ cardiac work demand
  • By relaxing vascular smooth muscle
  • By reducing blood volume
  • Inhibit the Renin-Angiotensin-Aldosterone-System (RAAS)
  • Prevent inappropriate ↑ in heart rate
  • Mobilise the oedematous fluids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

non-pharmalogical treatment of LVSD

A
  1. Lifestyle factors – as per all CVD conditions, remember mental health factors
  2. “Device therapy”
    • Pacing
    • Cardiac Resynchronisation Therapy
    • Implantable Cardiac Defibrillators
    • Coronary revascularisation
    • Heart transplant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Main Drugs Used in chronic Heart Failure (HFrEF)

THINK ABBA Waterloo

A
  • loop diuretics
  • ACE inhibitors
  • angiotensin II receptor blockers
  • beta-blockers
  • aldosterone receptor antagonists
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

step 1 in treatment of chronic heart failure

THINK DAB

A

(Diuretics if they are experiencing fluid retention)
A = ace inhibitors or ARB)
B = Beta Blocker

Waterloo = diuretics sometimes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Kidney function modifiers in HF

A

Increase excretion of sodium and water

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

two steps in the process which increases the excretion of sodium and water in HF

A
Loop diuretics (step 1)
- furosemide, bumetanide
Aldosterone receptor antagonists (step 2) - spironolactone
PCT = Proximal convoluted tubule 
TAL = Thick ascending loop
DT = Distal tubule
CT = Collecting tubule
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Patient self-management with education

A
  • daily weights – if varies in either direction, alter dose
  • Symptom review – breathlessness, peripheral oedema
  • Thirst level, dizziness, “washed out”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Loop Diuretics (e.g. furosemide, bumetanide) common side-effects

A
  • Electrolyte disturbances –low K, Na, Mg, Ca • Hypotension
  • Renal impairment – measure eGFR
  • Hypovolaemia!
  • Nocturia if taken too late in day (troublesome)
  • Acute gout common with high doses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Renin Angiotensin System Inhibitors

A
  • Use in HF with reduced EF of all NYHA classes

* Reduces morbidity/mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Angiotensin converting enzyme inhibitors

A
  • ramipril, lisinopril
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Angiotensin AT1 receptor antagonists

A
  • candesartan, valsartan, (losartan)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Using the ACEI and ARBs in HF

A
  • Reduce salt and water retention
  • Reduce vasoconstriction
  • Reduce vascular resistance
  • Reduce afterload
  • Improve tissue perfusion
  • Reduces ventricular remodelling and hypertrophy
  • Less effective in African or Caribbean ethnicity (try hydralazine+nitrate)
  • Start low dose, monitoring BP & blood chemistry and symptoms and uptitrating to maximum tolerated or target doses.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

renin-Angiotensin system inhibitors : Side effects/cautions

A

• Dizziness
• headache
• Persistentdrycough, tiredness, rare but serious – angioedema
•Risk of hyperkalaemia (care with drug which also raise K+)
• Renal impairment - can be reno-protective also
Angiotensin AT1 receptor antagonists (ARBs)
• Avoid in bilateral renal artery stenosis
• back/legpain
• teratogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

angiotensin coveting enzyme inhibitors side effects

A

• Persistent dry cough, tiredness, rare but serious – angioedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Angiotensin AT1 receptor antagonists (ARBs) side effects

A

back/leg pain

17
Q

Why Use Beta-Blockers in HF?

A

may slow HR, which could decrease CO

  • allows ventricle to fill more completely during diastole
  • Some Beta-blockers (e.g. carvedilol) cause vasodilation through blockage of alpha-receptors,  ↓ afterload
  • Reduce renin release by kidney
18
Q

Beta-blockers for HF

A

Carvedilol, Bisoprolol

  • Start if reduced ejection fraction but stable NYHA class II-IV
  • Start low, go slow
  • reduces mortality
  • Seek specialist advice if severe HF, current exacerbation of HF, heart block or bradycardia, persisting signs of fluid overload, low BP (SBP<90mmHg)
19
Q
  • drug interactions of beta blockers
A

– risk of bradycardia/AV block with: digoxin, amiodarone, verapamil, diltiazem

20
Q

Beta-blockers side-effect examples

A
  • Bradycardia /Heart Block (contra-indicated)
  • Fatigue
  • Shortness of breath (Contra-indicated in Asthma)
  • Dizziness, cold peripheries, impotence/reduced libido, insomnia (more with older versions)
21
Q

adding aldosterone antagonists

A
  • spironolactone, eplerenone
  • Add in if on ACEI or ARB + Beta-blocker + diuretic (“DAB”) and still symptoms
  • In NYHA class II-IV failure (effective in severe heart failure )
  • low doses used
  • Reduces symptoms and mortality
22
Q

Aldosterone Receptor Antagonists - Common side effects

A
  • Hyperkalaemia
  • hyponatraemia
  • Nausea
  • Hypotension
  • gynaecomastia with spironolactone •renal impairment
23
Q

Management of HF drug adverse effects

A
  • Flexible dosing for DABs, may need to up and down titrate.
  • Review BP – may be low but is patient symptomatic?
  • Bradycardia – if symptomatic may need to stop beta-blocker or review any other rate controlling drugs patient on . If HR<45 BPM – stop beta-blocker, call specialist
24
Q

Step3or4 in treatment of HF

A
  • Sacubitril (Neprilysin inhibitor)– Valsartan (ARB) combination
  • Ivabradine, specialist use only – reduces heart rate but not contractility, acts on sinus node. Use only if heart rate > 75 (in SR)
25
Persistent sodium/water retention
– Additional diuretics (e.g. thiazides like metolazone)
26
Co-existing angina
– Oral nitrates | – Amlodipine (care!)
27
Atrial fibrillation
– Digoxin • shows no reduction in mortality rate • narrow therapeutic window
28
mechanism of action in digoxin in AF
↑ vagal efferent activity to the heart  ↓ SAN firing rate (↓ HR) and ↓ conduction velocity in the AV node
29
mechanism of action in digoxin in heart failure
Increases force of myocardial contraction – Inhibits Na/KATP-ase pump, thus affecting Na/Ca exchanger, elevating intracellular calcium levels in Sarcoplasmic Reticulum then when Calcium released results in strengthened contractility • i.e. indirectly increases calcium levels and subsequent storage in the SR
30
Digoxin side- | effects/toxicity
* GIupset * dizziness * Conduction abnormalities * Blurred or yellow vision
31
Treatment of Acute (decompensated) Heart Failure
Sudden worsening of signs and symptoms of heart failure as a result of severe congestion of multiple organs. Increased dyspnoea, oedema
32
Acute (decompensated) Heart Failure causes
MI, infection, anaemia, thyroid dysfunction, arrhythmia, uncontrolled hypertension, poor concordance
33
Acute (decompensated) Heart Failure aims of the treatment
* Normalise ventricular filling pressures | * Restore adequate tissue perfusion
34
Treatment of Acute Heart Failure: First Line Drug Treatments:
LMNOP
35
Treatment of Acute Heart Failure: second line
By use of inotropic agents (examples later) ↑ contractility will ↑ stroke volume, which ↑ Cardiac output (CO) so ↑ clearance of pooled blood in the ventricles As CO increases, baroreceptors sense change in MABP and ↓ sympathe$c drive and so ↓ HR and ↓ TPR
36
Inotropes - beta-agonists - increase myocardial contractility
– Dobutamine (beta 1&2) - in patients with cardiogenic shock to maintain blood pressure – Dopamine (DA > Beta > alpha) - Increases renal perfusion at low doses, can increase BP at high doses – Isoprenaline – in bradycardia/heart block emergencies - Adrenaline (beta>alpha)
37
Vasopressors
– Noradrenaline (alpha>beta) – cause vasoconstriction, raise BP, used in severe septic shock